Fact CheckerSign in

NCT07705620Not yet recruiting

A Behavioral Digital Intervention For Parkinson's Disease

A Behavioral Digital Intervention For Parkinson's Disease: Protocol For A Quasi-Experimental Study Examining Feasibility, Physical Activity, And Exploratory Patient-Reported Outcomes

Source: ClinicalTrials.gov · Last updated 16 Jul 2026

Brief summary (registry, in English)

The goal of this interventional, quasi-experimental study is to evaluate whether a digital dual-task exercise and behavioral program can improve physical activity and influence patient-reported outcomes in people with Parkinson's disease. The main questions it aims to answer are: 1. Is the MOVE ON UP digital intervention feasible and acceptable, based on recruitment, retention, adherence, and safety? 2. Does participation in the program lead to increased physical activity levels? 3. Does the intervention produce exploratory improvements in patient-reported outcomes such as motor symptoms, balance confidence, and quality of life? Because the study includes a comparison group, researchers will compare participants receiving the MOVE ON UP digital intervention with participants receiving usual care to determine whether the digital program produces measurable behavioral and functional changes. Participants will: 1. Complete baseline and post-intervention assessments of physical activity and patient-reported outcomes. 2. Engage in an 8-week digital dual-task exercise program, including: 2.1 Structured dual-task exercise sessions delivered digitally. 2.2 Educational content related to Parkinson's disease and physical activity. 2.3 Behavioral support elements informed by the COM-B model. 3. Use the digital platform to follow the program and complete follow-up questionnaires.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
68 (estimated)
First submitted
10 Jul 2026
Start date
2 Nov 2026
Primary completion date
30 Jul 2027
Lead sponsor
Egas Moniz - Cooperativa de Ensino Superior, CRL
NCT number
NCT07705620

What you commit to

  • Study type: Interventional
  • Planned participants: 68
  • From 2 Nov 2026 to the primary completion date, 30 Jul 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Anticipated inability to complete the 8-week intervention period due to planned surgery, extended travel, or other commitments
    • Participants with a caregiver willing to assist with technology, assessments, or exercise supervision are not excluded; caregiver involvement will be documented and considered in exploratory analyses where appropriate.

Other illness

  • Self-reported severe cognitive impairment that would preclude understanding and following exercise instructions, based on clinical judgment of referring provider or study coordinator following screening conversation
  • Significant active psychiatric problems (e.g., untreated major depression, psychosis, substance abuse) that would interfere with participation or adherence
  • Medical conditions contraindicating moderate-intensity exercise, including:
    • Unstable cardiovascular disease (uncontrolled hypertension, recent myocardial infarction, unstable angina) Severe orthopedic limitations (acute fractures, severe osteoarthritis limiting mobility) Other systemic conditions that would make participation unsafe as determined by the participant's physician or study coordinator during screening

Other

  • Pregnancy

Who the study is looking for

  • Diagnosis of idiopathic Parkinson's disease (self-reported; verification requested from treating physician or neurologist when possible)
  • Hoehn and Yahr stages I-IV (mild to moderate disease severity; ambulatory with or without assistance)
  • Age 18 years or older
  • Access to a computer, tablet, or smartphone with reliable internet connection
  • Basic digital literacy to navigate the study website (caregiver assistance permitted if needed)
  • Ability to communicate with study personnel in the local language (Portuguese, Greek, Croatian, or Italian) to understand instructions and provide informed consent
  • Willingness and ability to provide written informed consent electronically prior to enrolment
  • For those completing remote assessments, willingness to complete self-assessments with or without caregiver assistance following provided video instructions

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.